combination therapies outperforming semaglutide Teaching obesity/weight management this week for our P2s, so here's a post on incretin therapy for weight loss! 💊 Incretin-based therapy, including the GLP-1 agonists liraglutide and and the GLP-1/GIP dual Semaglutide vs Tirzepatide 💉⚖️ Both

Bloating occurs because Ozempic slows the movement of food through your digestive tract

Global GLP-1 Receptor Agonist Market Size: Forecast (2026-2032) The Global GLP-1 Receptor Agonist Market size was valued at around USD 52.39 billion in 2025 and is projected to grow from USD 63.2 billion in 2026 to USD 78.4 billion by 2032

For tomograms acquired at 36000 x magnification, gold particles were detected using findbeads3d and were sorted based on their location (intracellular, extracellular, presynaptic, postsynaptic, SVs, endosomes and multivesicular bodies)

The medication slows stomach emptying and promotes satiety, which can complicate symptom management when your body is already dealing with illness